北美生物技术市场，按产品类型（仪器、试剂、服务和软件）、技术（纳米生物技术、PCR技术、DNA测序、色谱法、组织工程和再生、基于细胞的测定、发酵等）、应用（生物制药、生物工业、生物服务、生物信息学和生物农业）、最终用户（制药和生物技术公司、合同研究组织、学术和研究机构等）、分销渠道（直接招标、第三方分销商等）、国家（美国、加拿大、墨西哥）行业趋势和预测到 2028 年。
市场分析和洞察：北美生物技术市场
预计生物技术市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，市场复合年增长率为 27.9%，预计到 2028 年将达到 2,691,409.16 百万美元。慢性病患病率的上升需要先进的生物技术产品和仪器，这是生物技术市场增长的驱动力。
生物技术是一种利用生物系统、生物体或其部分来开发或创造不同产品的技术。酿造和烘烤面包是属于生物技术概念的工艺实例（使用酵母（生物体）来生产所需产品）。这种传统工艺通常利用天然形式的生物体（或通过育种进一步开发），而更现代的生物技术形式通常涉及对生物系统或生物体的更高级改造。如今，生物技术涵盖许多不同的学科（例如遗传学、生物化学和分子生物学等）。每年都会在医学（开发新药和新疗法）、农业（开发转基因植物、生物燃料、生物处理）或工业生物技术（生产化学品、纸张、纺织品和食品）领域开发新技术和新产品。
由于慢性病发病率的增加和技术进步，生物技术市场正在增长。此外，产品批准数量的增加是加速生物技术市场增长的另一个因素。缺乏熟练的专业人员预计将抑制全球生物技术市场的增长。
生物技术市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和生物技术市场情景，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
生物技术市场范围和市场规模
生物技术市场根据产品类型、技术、应用、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品类型，生物技术市场分为仪器、试剂和服务与软件。2021 年，由于提供各种创新解决方案，预计仪器部门将主导生物技术市场。
- 根据技术，生物技术市场细分为纳米生物技术、PCR 技术、DNA 测序、色谱分析、组织工程和再生、基于细胞的测定、发酵等。2021 年，纳米生物技术领域预计将因其广泛的应用范围而主导生物技术市场。
- 根据应用，生物技术市场细分为生物制药、生物工业、生物服务、生物信息学和生物农业。由于研发活动数量不断增加，预计到 2021 年，生物制药领域将占据生物技术市场的主导地位。
- 根据最终用户，生物技术市场分为制药和生物技术公司、合同研究组织、学术和研究机构等。 2021 年，由于各种医疗组织和政府机构为鼓励研究工作而采取的主动行动不断增加，制药和生物技术公司部门预计将在生物技术市场中占据主导地位。
- 根据分销渠道，生物技术市场分为直接招标、第三方分销商和其他。由于对生物技术仪器的需求不断增长，预计到 2021 年，直接招标部分将主导生物技术市场。
生物技术市场国家层面分析
对生物技术市场进行分析，并按上述国家、产品类型、技术、应用、最终用户和分销渠道提供市场规模信息。
生物技术市场报告涵盖的国家包括美国、加拿大和墨西哥。
- 在北美，由于 FDA 批准的生物技术仪器数量不断增加，预计美国将占据市场主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
主要市场参与者不断增加的战略活动增强了对生物技术的认识，推动了市场的增长
生物技术市场还为您提供每个国家特定市场增长的详细市场分析。此外，它还提供有关市场参与者战略及其地理分布的详细信息。数据适用于 2010 年至 2019 年的历史时期。
竞争格局和生物技术市场份额分析
生物技术市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对生物技术市场的关注有关。
从事生物技术业务的主要公司包括 Trinity Biotech、Thermo Fisher Scientific Inc.、Abbott、F. Hoffmann-La Roche Ltd、Charles River Laboratories、Eurofins Scientific、Promega Corporation、Bio-Rad Laboratories, Inc.、PerkinElmer Inc.、Takara Bio Inc.、Ortho Clinical Diagnostics、QIAGEN、Agilent Technologies, Inc.、AstraZeneca、Merck KGaA、bioMérieux SA、Myriad Genetics, Inc.、Illumina, Inc.、Pacific Biosciences of California, Inc. 和 Biogen 等国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
全球各地的公司也纷纷签订合同和协议，这也加速了生物技术市场的发展。
例如，
- 2021 年 2 月，赛默飞世尔科技公司宣布已完成之前宣布的对 Mesa Biotech, Inc. 的收购。此次收购预计将加强公司在生物技术市场的领导地位。
- 2021 年 3 月，Charles River Laboratories 宣布收购 Retrogenix Limited，这是一家早期合同研究组织 (CRO)，利用其专有的细胞微阵列技术提供专业的生物分析服务。此次收购有望加强公司的生物分析业务部门。
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在生物技术市场的影响力，这也为组织的利润增长带来了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA BIOTECHNOLOGY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 NORTH AMERICA BIOTECHNOLOGY MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING GERIATRIC POPULATION
5.1.2 GROWING PREVALENCE OF CHRONIC DISEASES
5.1.3 INCREASING TECHNOLOGICAL ADVANCEMENTS
5.1.4 WIDE RANGE OF APPLICATION
5.1.5 RISING FUNDING AND INVESTMENTS FOR THE DEVELOPMENT OF BIOTECHNOLOGY TECHNIQUES
5.2 RESTRAINTS
5.2.1 GROWING PACE OF PRODUCT RECALL
5.2.2 HIGH COST OF BIOTECHNOLOGY INSTRUMENT
5.2.3 STRICT REGULATORY FRAMEWORK
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS
5.3.2 ESCALATION IN INNOVATION AND TECHNOLOGIES
5.3.3 RISING EXPENDITURE ON HEALTHCARE
5.4 CHALLENGES
5.4.1 SHORTAGE OF SKILLED PERSONNEL
5.4.2 LIMITATIONS OF DOWNSTREAM PURIFICATION
6 IMPACT OF COVID-19 ON THE NORTH AMERICA BIOTECHNOLOGY MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 STRATEGIC DECISIONS BY MANUFACTURERS
6.5 CONCLUSION
7 NORTH AMERICA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 INSTRUMENT
7.3 REAGENTS
7.4 SERVICES & SOFTWARE
8 NORTH AMERICA BIOTECHNOLOGY MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 NANO BIOTECHNOLOGY
8.3 NANOCRYSTALS
8.4 NANOPARTICLES
8.5 LIPOSOMES
8.6 MICELLES
8.7 OTHERS
8.8 PCR TECHNOLOGY
8.9 CONVENTIONAL PCR
8.1 REAL-TIME PCR (QPCR)
8.11 DIGITAL PCR (DPCR)
8.12 REVERSE TRANSCRIPTION PCR (RT-PCR)
8.13 OTHER PCR
8.14 DNA SEQUENCING
8.15 SEQUENCING BY SYNTHESIS
8.16 ION SEMICONDUCTOR SEQUENCING
8.17 SEQUENCING BY LIGATION
8.18 PYROSEQUENCING
8.19 SINGLE MOLECULE REAL-TIME SEQUENCING
8.2 CHAIN TERMINATION SEQUENCING
8.21 NANOPORE SEQUENCING
8.22 CHROMATOGRAPHY
8.23 GAS CHROMATOGRAPHY
8.24 LIQUID CHROMATOGRAPHY
8.25 THIN LAYER CHROMATOGRAPHY
8.26 SUPERCRITICAL FLUID CHROMATOGRAPHY
8.27 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY/ULTRA HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC/UHPLC)
8.28 AFFINITY CHROMATOGRAPHY
8.29 TISSUE ENGINEERING AND REGENERATION
8.3 IMMUNOISOLATION TECHNOLOGY
8.31 CELL CULTURE TECHNOLOGY
8.32 STEM CELL TECHNOLOGY
8.33 CELL-BASED ASSAYS
8.34 FLOW CYTOMETRY
8.35 AUTOMATED HANDLING
8.36 LABEL-FREE-DETECTION
8.37 HIGH-THROUGHPUT SCREENING
8.38 OTHERS
8.39 FERMENTATION
8.4 UPSTREAM PROCESS
8.41 DOWNSTREAM PROCESS
8.42 OTHERS
9 NORTH AMERICA BIOTECHNOLOGY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BIOPHARMACY
9.3 BIOINDUSTRIAL
9.4 BIOSERVICES
9.5 BIOINFORMATICS
9.6 BIOAGRICULTURE
10 NORTH AMERICA BIOTECHNOLOGY MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 CONTRACT RESEARCH ORGANIZATIONS
10.4 ACADEMIC & RESEARCH INSTITUTES
10.5 OTHERS
11 NORTH AMERICA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 NORTH AMERICA BIOTECHNOLOGY MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA BIOTECHNOLOGY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 F. HOFFMANN-LA ROCHE LTD
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ASTRAZENECA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 MERCK KGAA
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 ABBOTT
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BIOGEN
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BIOMÉRIEUX SA
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIO-RAD LABORATORIES, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 CHARLES RIVER LABORATORIES
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 EUROFINS SCIENTIFIC
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 ILLUMINA, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 MYRIAD GENETICS, INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 ORTHO CLINICAL DIAGNOSTICS.
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS
15.15 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 PERKINELMER INC.
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 PROMEGA CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.18 TAKARA BIO INC.
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 TRINITY BIOTECH
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 QIAGEN
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA CANCER INCIDENCE IN BOTH THE GENDERS (2018)
TABLE 2 NORTH AMERICA CANCER INCIDENCE IN MEN (2018)
TABLE 3 NORTH AMERICA CANCER INCIDENCE IN WOMEN (2018)
TABLE 4 NORTH AMERICA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA INSTRUMENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA REAGENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA SERVICES & SOFTWARE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA FERMENTATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA BIOPHARMACY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA BIOINDUSTRIAL IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA BIOSERVICES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA BIOINFORMATICS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA BIOAGRICULTURE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA DIRECT TENDER IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 U.S. BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 53 U.S. BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 54 U.S. FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 55 U.S. TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 56 U.S. PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 57 U.S. NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 U.S. CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 59 U.S. DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 60 U.S. CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 61 U.S. BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 62 U.S. BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 63 U.S. BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 CANADA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 CANADA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 CANADA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 67 CANADA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 68 CANADA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 69 CANADA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 70 CANADA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 71 CANADA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 72 CANADA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 73 CANADA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 CANADA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 75 CANADA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 76 MEXICO BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 77 MEXICO BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 78 MEXICO FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 79 MEXICO TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 80 MEXICO PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 81 MEXICO NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 MEXICO CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 83 MEXICO DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 84 MEXICO CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 85 MEXICO BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 MEXICO BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 MEXICO BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA BIOTECHNOLOGY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA BIOTECHNOLOGY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA BIOTECHNOLOGY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA BIOTECHNOLOGY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA BIOTECHNOLOGY MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA BIOTECHNOLOGY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA BIOTECHNOLOGY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA BIOTECHNOLOGY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA BIOTECHNOLOGY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA BIOTECHNOLOGY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GROWING PREVALENCE OF CHRONIC DISEASES IS DRIVING THE NORTH AMERICA BIOTECHNOLOGY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 INSTRUMENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BIOTECHNOLOGY MARKET IN 2021 & 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA BIOTECHNOLOGY MARKET
FIGURE 16 CANCER DEATH RATES BY AGE GROUP (2017)
FIGURE 17 NUMBER OF NEW CANCER CASES FOR ALL AGE GROUPS (IN 2018)
FIGURE 18 NUMBER OF NEW CASES IN MALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 19 NUMBER OF NEW CASES IN FEMALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 20 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2020
FIGURE 21 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 22 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 23 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 NORTH AMERICA BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2020
FIGURE 25 NORTH AMERICA BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 26 NORTH AMERICA BIOTECHNOLOGY MARKET : BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 27 NORTH AMERICA BIOTECHNOLOGY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 NORTH AMERICA BIOTECHNOLOGY MARKET : BY APPLICATION, 2020
FIGURE 29 NORTH AMERICA BIOTECHNOLOGY MARKET : BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 30 NORTH AMERICA BIOTECHNOLOGY MARKET : BY APPLICATION, CAGR (2021-2028)
FIGURE 31 NORTH AMERICA BIOTECHNOLOGY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 NORTH AMERICA BIOTECHNOLOGY MARKET: BY END USER, 2020
FIGURE 33 NORTH AMERICA BIOTECHNOLOGY MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 34 NORTH AMERICA BIOTECHNOLOGY MARKET: BY END USER, CAGR (2021-2028)
FIGURE 35 NORTH AMERICA BIOTECHNOLOGY MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 NORTH AMERICA BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 37 NORTH AMERICA BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 38 NORTH AMERICA BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 NORTH AMERICA BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 NORTH AMERICA BIOTECHNOLOGY MARKET: SNAPSHOT (2020)
FIGURE 41 NORTH AMERICA BIOTECHNOLOGY MARKET: BY COUNTRY (2020)
FIGURE 42 NORTH AMERICA BIOTECHNOLOGY MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 NORTH AMERICA BIOTECHNOLOGY MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 NORTH AMERICA BIOTECHNOLOGY MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 45 NORTH AMERICA BIOTECHNOLOGY MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
